TransMedics (TMDX) Depreciation & Amortization (CF) (2018 - 2026)

TransMedics has reported Depreciation & Amortization (CF) for 9 years, with the latest figure at $11.9 million in Q1 2026.

• For the quarter ending Q1 2026, Depreciation & Amortization (CF) rose 93.32% year-over-year to $11.9 million; the trailing twelve-month figure through Mar 2026 stood at $32.8 million (up 53.3% YoY), and the FY2025 full-year result was $27.2 million, up 37.59% from the prior year.
• Depreciation & Amortization (CF) for Q1 2026 stood at $11.9 million, up from $7.5 million in the prior quarter.
• The five-year high for Depreciation & Amortization (CF) was $11.9 million in Q1 2026, with the low at $507000.0 in Q1 2022.
• Average Depreciation & Amortization (CF) over 5 years is $4.1 million, with a median of $4.3 million recorded in 2024.
• Year-over-year, Depreciation & Amortization (CF) climbed 13.93% in 2022 and jumped 230.92% in 2024.
• Tracing TMDX's Depreciation & Amortization (CF) over 5 years: stood at $1.3 million in 2022, then surged by 180.54% to $3.6 million in 2023, then jumped by 57.56% to $5.7 million in 2024, then jumped by 31.48% to $7.5 million in 2025, then soared by 58.86% to $11.9 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $11.9 million (Q1 2026), $7.5 million (Q4 2025), and $6.8 million (Q3 2025), per Business Quant data.

Peer Comparison